EUVIMEDEUVIMED entdecken
Open Access

Targeted intracellular oral RNA delivery through tea polyphenol nanovesicle to outer membrane vesicle transfer for colitis treatment

Taisong Fang iD, Songbai Liu iD

Science Advances · 2026

DOI: 10.1126/sciadv.adx8336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Taisong Fang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Nutrition, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Colitis, Tea, Polyphenols, RNA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, “Pioneer” and “Leading Goose” R&D Program of Zhejiang, Zhejiang University Wencheng Grand Health Joint Research Center Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efficient oral delivery of RNA to the target site is a long-standing issue for nucleic acid–based therapy. Herein, we adopted a vesicle-to-vesicle transfer strategy and established an efficient approach to encapsulate and stabilize RNA for targeted oral delivery. The amphiphilic specifically acylated epigallocatechin directly performed encapsulation of RNA and generated nanovesicles in high efficiency without assistance of additional materials. The RNA encapsulated in the nanovesicles was efficiently transferred to outer membrane vesicles (OMVs) derived from Escherichia coli Nissle 1917 probiotic through membrane fusion with simple operation. The derived hybrid vesicles (HVs) were further anchored with bilirubin and Lys-Asp-Glu-Leu grafted hyaluronic acid (HA-BR-KDEL) ligand for sequential cellular and intracellular targeting to the endoplasmic reticulum of inflammatory cells in inflamed intestinal tract. Oral delivery of HVs@HA-BR-KDEL notably alleviated colitis symptoms in mice and contributed to the restoration of intestinal homeostasis. The tea polyphenol hybrid OMV strategy holds great promise for oral gene-mediated treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisTeaPolyphenolsRNAAnimalsMiceAdministration, OralEscherichia coli

Substanzen

TeaPolyphenolsRNA

Autor:innen und Institutionen

  • Department of Food Science and Nutrition, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.

ORCID-Profile: Taisong Fang, Songbai Liu

Förderung

  • National Natural Science Foundation of China
  • “Pioneer” and “Leading Goose” R&D Program of Zhejiang
  • Zhejiang University Wencheng Grand Health Joint Research Center Project
  • Foundation of Fuli Institute of Food Science at Zhejiang University

Zitieren

APA

Fang, T., & Liu, S. (2026). Targeted intracellular oral RNA delivery through tea polyphenol nanovesicle to outer membrane vesicle transfer for colitis treatment. Science Advances. https://doi.org/10.1126/sciadv.adx8336

Vancouver

Fang T, Liu S. Targeted intracellular oral RNA delivery through tea polyphenol nanovesicle to outer membrane vesicle transfer for colitis treatment. Science Advances. 2026. doi:10.1126/sciadv.adx8336

BibTeX
@article{Fang2026,
  author = {Fang, Taisong and Liu, Songbai},
  title = {Targeted intracellular oral RNA delivery through tea polyphenol nanovesicle to outer membrane vesicle transfer for colitis treatment},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.adx8336}
}
Kostenlos starten →